Dubbed Bayesian?: Why Adoption Is Slow in Drug Development - 10/27/2025
In last week's blog, I showed that the Frequentist/Bayesian divide is largely philosophical, with practical differences between approaches being limited. Even unique Bayesian methods can often be interpreted in a frequentist manner. Yet, adoption of these methods, dubbed Bayesian, even when appropriately applied, has been slow in drug development. This article explains why.